PP_1170x120_10-25-21

AUVI-Q AffordAbility program

Walgreens and kaléo team to address epinephrine auto-injector supply issues

Walgreens and kaléo team to address epinephrine auto-injector supply issues

DEERFIELD, Ill. and RICHMOND, Va. — Walgreens and kaléo, a privately-held pharmaceutical company, are working together to improve access to epinephrine auto-injectors by making kaléo’s AUVI-Q 0.15 mg and 0.3 mg available through Walgreens locations nationwide. This comes in an effort to help thousands of Americans with their epinephrine needs during the back to school